← All diseases
Heart and blood vessels
Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1417)
- Assessing microvascular dysfunction and predicting long-term prognosis in patients with cardiac amyloidosis by cardiovascular magnetic resonance quantitative stress perfusion. (2025/07/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis. (2025/06/10) ♡
- Comparison of two genetic strategies for diagnostic work-up of hypertrophic cardiomyopathy: impact on the diagnosis of Fabry disease or transthyretin amyloidosis. (2025/06/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. How to predict the presence of cardiac amyloidosis in patients with atrial fibrillation. (2025/06/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The effect of trimetazidine on cardiac haemodynamics and mitochondrial function in wild-type transthyretin amyloidosis. (2025/06/01) ♡
- Free-Breathing Ungated Radial Simultaneous Multi-Slice Cardiac T1 Mapping. (2025/06/01) ♡
- Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic. (2025/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac Amyloidosis in Older Adults With a Focus on Frailty: JACC: Advances Expert Consensus. (2025/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies. (2025/05/19) ♡
- Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in Cardiac Amyloidosis: A Systematic Review: Study protocol. (2025/05/05) ♡
- Cardiac Elastography With External Vibration for Quantification of Diastolic Myocardial Stiffness. (2025/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis. (2025/04/01) ♡
- Imaging of cardiac amyloidosis using dynamic (18)F-FPYBF-2 positron emission tomography. (2025/04/01) ♡
- Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan. (2025/04/01) ♡
- A scientometric study on research characteristics and trends of amyloidosis involving the oral cavity. (2025/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hypertensive heart disease in older patients: considerations for clinical practice. (2025/04/01) ♡
- Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations. (2025/03/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular outcomes of patients with atrial fibrillation and concomitant cardiac amyloidosis undergoing percutaneous catheter ablation. (2025/03/01) ♡
- Leveraging a Vision Transformer Model to Improve Diagnostic Accuracy of Cardiac Amyloidosis With Cardiac Magnetic Resonance. (2025/03/01) ♡
- Oxidative conversion of transthyretin in formalin-fixed clinical amyloid samples results in the formation of the His90Asp and His90Asn variants. (2025/03/01) ♡
- Evolving knowledge of red flag clinical features associated with TTR p.(Val142Ile) in a diverse electronic health-record-linked biobank. (2025/03/01) ♡
- Clinical and genetic features of AGel amyloidosis caused by novel gelsolin variant and its impact on cardiac function and conduction disorders. (2025/03/01) ♡
- Right ventricular coupling predicts cardiopulmonary fitness in cardiac transthyretin amyloidosis. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Echocardiographic findings of patients with transthyretin amyloid cardiomyopathy. (2025/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis. (2025/02/01) ♡
- Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region. (2025/02/01) ♡
- Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Disease-modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications. (2025/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. In Response to: Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis. (2025/02/01) ♡
- Echocardiographic index of left ventricular performance for prognostication in transthyretin cardiac amyloidosis: the central role of stroke volume index. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac amyloidosis: when to suspect and how to confirm. (2025/02/01) ♡
- Effect of Tafamidis on Clinical and Functional Parameters in Transthyretin Amyloid Cardiomyopathy. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in genetic diagnosis and therapy of hereditary heart disease: a bibliometric review from 2004 to 2024. (2025/01/08) ♡
- Predictors of Early Death in Patients With Wild-Type Transthyretin Cardiac Amyloidosis. (2025/01/07) ♡
- Predictive Value of Right Ventricular Sensing During Cardiac Device Implantation to Diagnose Cardiac Amyloidosis. (2025/01/01) ♡
- Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases. (2025/01/01) ♡
- Preprocedural Screening Tool to Guide Nonpulmonary Vein Trigger Testing in First-Time Atrial Fibrillation Ablation. (2025/01/01) ♡
- Impact of Region of Interest Size on Semi-Quantification of Myocardial (99m)Tc-pyrophosphate Uptake in Suspected Transthyretin Cardiac Amyloidosis. (2025/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nuclear Medicine Imaging for the Diagnosis of ATTR Cardiac Amyloidosis: Report of Japanese Society of Nuclear Cardiology Working Group. (2025/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Story of Localized Amyloidosis: Something Old and Something New - A Case Series. (2025/01/01) ♡
- [4. Cardiac Amyloidosis Imaging Using Nuclear Medicine]. (2025/01/01) ♡
- Clinical characteristics and management of patients with cardiac amyloidosis in clinical practice: analysis of a cohort of 33 patients. (2025/01/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Quantification methods for 99mTc-labelled disphosphonates uptake in cardiac amyloidosis. (2025/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Amyloidosis TTR Flow Reserve Evaluation (2025-12-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study Of MCG In Cardiac Amyloidosis (2025-12-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM (2025-12-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multimodality Cardiac Imaging for Disease Progression in ATTR-CM (2025-12-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac Amyloidosis Discovery Trial (2025-12-04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The CARDIO-TTRansform Scintigraphy Sub-study (2025-11-28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study (2025-11-28) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.